Figure 2From: Optimization of a high-throughput whole blood expression profiling methodology and its application to assess the pharmacodynamics of interferon (IFN) beta-1a or polyethylene glycol-conjugated IFN beta-1a in healthy clinical trial subjectsGlobal scan quality. Addition of the cDNA probe in a DMSO buffer increases detection of expressed transcripts.Back to article page